Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ildikó Miklya
Observed names:
Ildiko Miklya,
Miklya, Ildikó
Institution:
Semmelweis University
Observed institutions:
Semmelweis University,
Hungarian Academy of Sciences
OpenAlex ID:
A5113766652
Pharmacological studies with endogenous enhancer substances: β-phenylethylamine, tryptamine, and their synthetic derivatives
2004
·
Seiichiro Shimazu
, Ildikó Miklya
·
Progress in Neuro-Psychopharmacology and Biological Psychiatry
·
57
Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain
1996
·
Joseph Knoll
, Ildikó Miklya
, et al.
·
Life Sciences
·
57
Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: Rationale for prophylactic (-)deprenyl (selegiline) medication
1995
·
Joseph Knoll
, Ildikó Miklya
·
Life Sciences
·
54
(−)1‐(Benzofuran‐2‐yl)‐2‐propylaminopentane, [(−)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain
1999
·
Joseph Knoll
, Fumio Yoneda
, et al.
·
British Journal of Pharmacology
·
53
PDF
(−)Deprenyl and (−)1-phenyl-2-propylaminopentane, [(−) PPAP] act primarily as potent stimulants of action potential — transmitter release coupling in the catecholaminergic neurons
1996
·
Joseph Knoll
, Ildikó Miklya
, et al.
·
Life Sciences
·
50
Sexual hormones terminate in the rat The significantly enhanced catecholaminergic/serotoninergic tone in the brain characteristic to the post-weaning period
2000
·
Joseph Knoll
, Ildikó Miklya
, et al.
·
Life Sciences
·
38
Stimulation of the catecholaminergic and serotoninergic neurons in the rat brain by R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane, (−)-BPAP
2002
·
Joseph Knoll
, Ildikó Miklya
, et al.
·
Life Sciences
·
16
High performing rats are more sensitive toward catecholaminergic activity enhancer (CAE) compounds than their low performing peers
1996
·
Joseph Knoll
, Berta Knoll
, et al.
·
Life Sciences
·
15
Major depression and the synthetic enhancer substances, (−)-deprenyl and R-(−)-1-(benzofuran-2-yl)-2-propylaminopentane
2005
·
Peter Gaszner
, Ildikó Miklya
·
Progress in Neuro-Psychopharmacology and Biological Psychiatry
·
13
Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice
2021
·
Judit Szepesy
, Viktória Humli
, et al.
·
International Journal of Molecular Sciences
·
10
PDF
1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (−)-BPAP in the shuttle box and leaves the effect of (−)-deprenyl unchanged
2002
·
Joseph Knoll
, Ildikó Miklya
, et al.
·
Life Sciences
·
10
Striking Neurochemical and Behavioral Differences in the Mode of Action of Selegiline and Rasagiline
2023
·
Laszlo G. Harsing
, Julia Timar
, et al.
·
International Journal of Molecular Sciences
·
9
PDF
Age-related decline of various cognitive functions in well-experienced male rats treated with the putative anti-aging compound (2R)-1-(1-benzofuran-2-yl)-N-propylpentane-2-amine ((-)BPAP)
2023
·
Aliz Judit Ernyey
, Ferenc Kassai
, et al.
·
GeroScience
·
9
PDF
Enhancer Regulation of Dopaminergic Neurochemical Transmission in the Striatum
2022
·
Laszlo Harsing
, Joseph Knoll
, et al.
·
International Journal of Molecular Sciences
·
9
PDF
[The role of alpha-synuclein in Parkinson's disease].
2014
·
Ildikó Miklya
, Noémi Pencz
, et al.
·
PubMed
·
9
Essential difference between the pharmacological spectrum of (−)-deprenyl and rasagiline
2014
·
Ildikó Miklya
·
Pharmacological Reports
·
8
Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain?
2025
·
Mahmoud Al-Khrasani
, Nariman Essmat
, et al.
·
Biomedicine & Pharmacotherapy
·
5
Inhibitory Effect of (2R)-1-(1-Benzofuran-2-yl)-N-propylpentan-2-amine on Lung Adenocarcinoma
2019
·
Zsolt Mervai
, Andrea Reszegi
, et al.
·
Pathology & Oncology Research
·
5
PDF
Synthetic enhancer compounds, besides acting on biogenic amine system, influence the glutamate transmission and stress response
2019
·
Joseph Knoll
, Dora Zelena
, et al.
·
Behavioural Brain Research
·
4
PDF
Protective Effect of Selegiline (R-deprenyl) in Aminoglycoside-Induced Hearing Loss
2025
·
Viktória Humli
, Judit Szepesy
, et al.
·
Neurochemical Research
·
2
PDF
[A comparison of the pharmacology of (-)-deprenyl to N-methylpropargylamine-1-aminoindane (J-508) and rasagiline, the desmethyl-analogue of J-508].
2008
·
Ildikó Miklya
·
PubMed
·
2
The use of the synthetic enhancer substances (-)-deprenyl and (-)-BPAP in major depression.
2004
·
Peter Gaszner
, Ildikó Miklya
·
PubMed
·
2
Phenylephrine per se or Combined with Pregabalin Ameliorates Mononeuropathic Pain in Rats
2026
·
Sarah Kadhim Abbood
, Nariman Essmat
, et al.
·
Pharmaceutics
·
1
PDF
Crosstalk Between Glycinergic and N-Methyl-D-Aspartate Receptor-Mediated Glutamatergic Transmission in Behaviours Associated with Opioid Use Disorder
2025
·
Nariman Essmat
, Imre Boldizsár
, et al.
·
International Journal of Molecular Sciences
·
1
PDF
Regulation by Trace Amine-Associated Receptor 1 (TAAR1) of Dopaminergic-GABAergic Interaction in the Striatum: Effects of the Enhancer Drug (-)BPAP
2025
·
Laszlo G. Harsing
, Gábor Szénási
, et al.
·
Neurochemical Research
·
1
PDF
Show more works
View as search
Works count:
39
Citation count:
445
H-index:
10
I10-index:
11
Year
Topic
Type
